Thermo Fisher 2026年4月2日 Thermo Fisher Scientific Introduces the Gibco™ CTS™ Compleo™ Fill and Finish System to Help Streamline Cell Therapy Manufacturing - Eagle-Tribune
Thermo Fisher 2026年4月2日 Thermo Fisher Scientific Introduces the Gibco™ CTS™ Compleo™ Fill and Finish System to Help Streamline Cell Therapy Manufacturing - The Joplin Globe
Thermo Fisher 2026年4月2日 Thermo Fisher Scientific Introduces the Gibco™ CTS™ Compleo™ Fill and Finish System to Help Streamline Cell Therapy Manufacturing - Bakersfield.com
Thermo Fisher 2026年4月2日 Thermo Fisher Scientific Introduces the Gibco™ CTS™ Compleo™ Fill and Finish System to Help Streamline Cell Therapy Manufacturing - Business Wire
Thermo Fisher 2026年4月2日 Thermo Fisher Scientific Introduces the Gibco™ CTS™ Compleo™ Fill and Finish System to Help Streamline Cell Therapy Manufacturing - Morningstar
FierceBiotech 2026年4月2日 Immunovant’s FcRn inhibitor flunks phase 3 eye disease trials, validating biotech’s waning interest
Thermo Fisher 2026年4月2日 Why Thermo Fisher Scientific Inc. (NYSE:TMO) Could Be Worth Watching - Yahoo Finance
Endpoints News 2026年4月2日 Alto Neuroscience shelves schizophrenia cognitive impairment program after Phase 2 miss
Endpoints News 2026年4月2日 Eli Lilly's chief technology officer retires after 35 years; Astellas strategy exec resigns
Endpoints News 2026年4月2日 Immunovant's FcRn drug fails in a pair of Phase 3 trials in thyroid eye disease